Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bioadaptives Inc - SIC # 5499 - MISCELLANEOUS FOOD STORES
Ticker
Exchange
SIC #
Website
Latest Ticker
BDPT
Over the counter
5499
https://www.shopbioadaptives.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bioadaptives Inc
BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs
- Sep 27th, 2023 12:00 pm
LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors
- Sep 14th, 2023 12:00 pm
BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs
- Sep 8th, 2023 12:00 pm
BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets
- Apr 20th, 2023 12:00 pm
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans
- Apr 18th, 2023 12:00 pm
BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD
- Apr 13th, 2023 12:00 pm
BioAdaptives, Inc. (OTC BDPT) Announces the Appointment of Flying C Bar Ranch Therapy Division as Its Exclusive Marketing Agent for Its LiveStock Impact Line of Performance Equine and Pet Supplements
- Apr 11th, 2023 12:00 pm
BioAdaptives Announces Signing of Non-Exclusive Marketing Agreement With World Wellness, LLC for the Launching of Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products
- Apr 6th, 2023 12:00 pm
BioAdaptives, Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Internationally Acclaimed Health Scientist, Author and Patent Holder, Dr. Yaguang Liu
- Apr 5th, 2023 12:00 pm
BioAdaptives Inc. Announced Today the Signing of a License for Eye Health due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000
- Mar 30th, 2023 12:00 pm
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management
- Mar 28th, 2023 12:00 pm
BioAdaptives Announces Signing of Letter of Intent With World Wellness, LLC for the Launching of Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products
- Mar 23rd, 2023 12:00 pm
BioAdaptives, Inc. Establishes a Wholesale Division to Expand Marketing Presence in a USD 151.9 Billion Global Dietary Supplement Market
- Dec 8th, 2022 1:00 pm
BioAdaptives, Inc. Introduces PROTEINnMORE, an Advanced, Plant-Based Lean Muscle Supplement for Fitness and Athletic Peak Performance
- Dec 1st, 2022 1:00 pm
As Global Anti-aging Product Annual Sales are Expected to Exceed 44 Billion by 2027, BioAdaptives, Inc. Launches Cell Rejuven, an Advanced, Plant-Based Anti-Aging Supplement With Rejuvenating Effects
- Nov 17th, 2022 1:00 pm
Scroll